Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 290

1.

Integrating proteomic, sociodemographic and clinical data to predict future depression diagnosis in subthreshold symptomatic individuals.

Han SYS, Cooper JD, Ozcan S, Rustogi N, Penninx BWJH, Bahn S.

Transl Psychiatry. 2019 Nov 7;9(1):277. doi: 10.1038/s41398-019-0623-2.

2.

Converging evidence points towards a role of insulin signaling in regulating compulsive behavior.

van de Vondervoort IIGM, Amiri H, Bruchhage MMK, Oomen CA, Rustogi N, Cooper JD, van Asten JJA, Heerschap A, Bahn S, Williams SCR, Buitelaar JK, Poelmans G, Glennon JC.

Transl Psychiatry. 2019 Sep 12;9(1):225. doi: 10.1038/s41398-019-0559-6.

3.

Innate Immune Cells and C-Reactive Protein in Acute First-Episode Psychosis and Schizophrenia: Relationship to Psychopathology and Treatment.

Steiner J, Frodl T, Schiltz K, Dobrowolny H, Jacobs R, Fernandes BS, Guest PC, Meyer-Lotz G, Borucki K, Bahn S, Bogerts B, Falkai P, Bernstein HG.

Schizophr Bull. 2019 Aug 29. pii: sbz068. doi: 10.1093/schbul/sbz068. [Epub ahead of print]

PMID:
31504969
4.

Increased serum levels of leptin and insulin in both schizophrenia and major depressive disorder: A cross-disorder proteomics analysis.

Çakici N, Bot M, Lamers F, Janssen T, van der Spek PJ, de Haan L, Bahn S, Penninx BWJH, van Beveren NJM.

Eur Neuropsychopharmacol. 2019 Jul;29(7):835-846. doi: 10.1016/j.euroneuro.2019.05.010. Epub 2019 Jun 21.

PMID:
31230885
5.

Drug discovery for psychiatric disorders using high-content single-cell screening of signaling network responses ex vivo.

Lago SG, Tomasik J, van Rees GF, Steeb H, Cox DA, Rustogi N, Ramsey JM, Bishop JA, Petryshen T, Haggarty SJ, Vázquez-Bourgon J, Papiol S, Suarez-Pinilla P, Crespo-Facorro B, van Beveren NJ, Bahn S.

Sci Adv. 2019 May 8;5(5):eaau9093. doi: 10.1126/sciadv.aau9093. eCollection 2019 May.

6.

Association of Insulin Resistance With Schizophrenia Polygenic Risk Score and Response to Antipsychotic Treatment.

Tomasik J, Lago SG, Vázquez-Bourgon J, Papiol S, Suárez-Pinilla P, Crespo-Facorro B, Bahn S.

JAMA Psychiatry. 2019 Apr 3. doi: 10.1001/jamapsychiatry.2019.0304. [Epub ahead of print] No abstract available.

PMID:
30942838
7.

Multimodel inference for biomarker development: an application to schizophrenia.

Cooper JD, Han SYS, Tomasik J, Ozcan S, Rustogi N, van Beveren NJM, Leweke FM, Bahn S.

Transl Psychiatry. 2019 Feb 11;9(1):83. doi: 10.1038/s41398-019-0419-4.

8.

PLDα1-knockdown soybean seeds display higher unsaturated glycerolipid contents and seed vigor in high temperature and humidity environments.

Zhang G, Bahn SC, Wang G, Zhang Y, Chen B, Zhang Y, Wang X, Zhao J.

Biotechnol Biofuels. 2019 Jan 4;12:9. doi: 10.1186/s13068-018-1340-4. eCollection 2019.

9.

Temporal proteomic profiling of postnatal human cortical development.

Breen MS, Ozcan S, Ramsey JM, Wang Z, Ma'ayan A, Rustogi N, Gottschalk MG, Webster MJ, Weickert CS, Buxbaum JD, Bahn S.

Transl Psychiatry. 2018 Dec 5;8(1):267. doi: 10.1038/s41398-018-0306-4.

10.

Safety and Usability Guidelines of Clinical Information Systems Integrating Clinical Workflow: A Systematic Review.

Lee Y, Jung MY, Shin GW, Bahn S, Park T, Cho I, Lee JH.

Healthc Inform Res. 2018 Jul;24(3):157-169. doi: 10.4258/hir.2018.24.3.157. Epub 2018 Jul 31.

11.

Exploring the neuropsychiatric spectrum using high-content functional analysis of single-cell signaling networks.

Lago SG, Tomasik J, van Rees GF, Ramsey JM, Haenisch F, Cooper JD, Broek JA, Suarez-Pinilla P, Ruland T, Auyeug B, Mikova O, Kabacs N, Arolt V, Baron-Cohen S, Crespo-Facorro B, Bahn S.

Mol Psychiatry. 2018 Jul 23. doi: 10.1038/s41380-018-0123-4. [Epub ahead of print]

PMID:
30038233
12.

Clinical Trials and Therapeutic Rationale for Drug Repurposing in Schizophrenia.

Lago SG, Bahn S.

ACS Chem Neurosci. 2019 Jan 16;10(1):58-78. doi: 10.1021/acschemneuro.8b00205. Epub 2018 Jul 18.

PMID:
29944339
13.

Virus discovery analyses on post-mortem brain tissue and cerebrospinal fluid of schizophrenia patients.

Tomasik J, Smits SL, Leweke FM, Eljasz P, Pas S, Kahn RS, Osterhaus ADME, Bahn S, de Witte LD.

Schizophr Res. 2018 Jul;197:605-606. doi: 10.1016/j.schres.2018.02.012. Epub 2018 Feb 23. No abstract available.

PMID:
29478863
14.

Proteomic approaches to identify blood-based biomarkers for depression and bipolar disorders.

Preece RL, Han SYS, Bahn S.

Expert Rev Proteomics. 2018 Apr;15(4):325-340. doi: 10.1080/14789450.2018.1444483. Epub 2018 Feb 27. Review.

PMID:
29466886
15.

Allostatic load is associated with psychotic symptoms and decreases with antipsychotic treatment in patients with schizophrenia and first-episode psychosis.

Berger M, Juster RP, Westphal S, Amminger GP, Bogerts B, Schiltz K, Bahn S, Steiner J, Sarnyai Z.

Psychoneuroendocrinology. 2018 Apr;90:35-42. doi: 10.1016/j.psyneuen.2018.02.001. Epub 2018 Feb 5.

PMID:
29427955
16.

Dendritic cell immunotherapy followed by cART interruption during HIV-1 infection induces plasma protein markers of cellular immunity and neutrophil recruitment.

van den Ham HJ, Cooper JD, Tomasik J, Bahn S, Aerts JL, Osterhaus ADME, Gruters RA, Andeweg AC; DC-TRN trial investigators.

PLoS One. 2018 Feb 1;13(2):e0192278. doi: 10.1371/journal.pone.0192278. eCollection 2018.

17.

Development of Safety and Usability Guideline for Hospital Information System.

Lee Y, Jung MY, Shin GW, Bahn S, Park T, Lee JH.

Stud Health Technol Inform. 2017;245:1368.

PMID:
29295447
18.

Schizophrenia-risk and urban birth are associated with proteomic changes in neonatal dried blood spots.

Cooper JD, Ozcan S, Gardner RM, Rustogi N, Wicks S, van Rees GF, Leweke FM, Dalman C, Karlsson H, Bahn S.

Transl Psychiatry. 2017 Dec 18;7(12):1290. doi: 10.1038/s41398-017-0027-0.

19.

Fluoxetine, not donepezil, reverses anhedonia, cognitive dysfunctions and hippocampal proteome changes during repeated social defeat exposure.

Gottschalk MG, Mortas P, Haman M, Ozcan S, Biemans B, Bahn S.

Eur Neuropsychopharmacol. 2018 Jan;28(1):195-210. doi: 10.1016/j.euroneuro.2017.11.002. Epub 2017 Nov 27.

PMID:
29174946
20.

Evidence of microglial activation following exposure to serum from first-onset drug-naïve schizophrenia patients.

van Rees GF, Lago SG, Cox DA, Tomasik J, Rustogi N, Weigelt K, Ozcan S, Cooper J, Drexhage H, Leweke FM, Bahn S.

Brain Behav Immun. 2018 Jan;67:364-373. doi: 10.1016/j.bbi.2017.10.003. Epub 2017 Oct 4.

PMID:
28988033
21.

Associations between SNPs and immune-related circulating proteins in schizophrenia.

Chan MK, Cooper JD, Heilmann-Heimbach S, Frank J, Witt SH, Nöthen MM, Steiner J, Rietschel M, Bahn S.

Sci Rep. 2017 Oct 3;7(1):12586. doi: 10.1038/s41598-017-12986-0.

22.

Control of nacre biomineralization by Pif80 in pearl oyster.

Bahn SY, Jo BH, Choi YS, Cha HJ.

Sci Adv. 2017 Aug 2;3(8):e1700765. doi: 10.1126/sciadv.1700765. eCollection 2017 Aug.

23.

A brain proteomic investigation of rapamycin effects in the Tsc1+/- mouse model.

Wesseling H, Elgersma Y, Bahn S.

Mol Autism. 2017 Aug 1;8:41. doi: 10.1186/s13229-017-0151-y. eCollection 2017.

24.

Pathogen-mediated NMDA receptor autoimmunity and cellular barrier dysfunction in schizophrenia.

Kannan G, Gressitt KL, Yang S, Stallings CR, Katsafanas E, Schweinfurth LA, Savage CLG, Adamos MB, Sweeney KM, Origoni AE, Khushalani S, Bahn S, Leweke FM, Dickerson FB, Yolken RH, Pletnikov MV, Severance EG.

Transl Psychiatry. 2017 Aug 1;7(8):e1186. doi: 10.1038/tp.2017.162.

25.
26.

Towards reproducible MRM based biomarker discovery using dried blood spots.

Ozcan S, Cooper JD, Lago SG, Kenny D, Rustogi N, Stocki P, Bahn S.

Sci Rep. 2017 Mar 27;7:45178. doi: 10.1038/srep45178.

27.

Alteration of Neuronal Excitability and Short-Term Synaptic Plasticity in the Prefrontal Cortex of a Mouse Model of Mental Illness.

Crabtree GW, Sun Z, Kvajo M, Broek JA, Fénelon K, McKellar H, Xiao L, Xu B, Bahn S, O'Donnell JM, Gogos JA.

J Neurosci. 2017 Apr 12;37(15):4158-4180. doi: 10.1523/JNEUROSCI.4345-15.2017. Epub 2017 Mar 10.

28.

Parallel changes in serum proteins and diffusion tensor imaging in methamphetamine-associated psychosis.

Breen MS, Uhlmann A, Ozcan S, Chan M, Pinto D, Bahn S, Stein DJ.

Sci Rep. 2017 Mar 2;7:43777. doi: 10.1038/srep43777.

29.

Lithium reverses behavioral and axonal transport-related changes associated with ANK3 bipolar disorder gene disruption.

Gottschalk MG, Leussis MP, Ruland T, Gjeluci K, Petryshen TL, Bahn S.

Eur Neuropsychopharmacol. 2017 Mar;27(3):274-288. doi: 10.1016/j.euroneuro.2017.01.001. Epub 2017 Jan 18.

PMID:
28109561
30.

Oxidative stress in drug-naïve first episode patients with schizophrenia and major depression: effects of disease acuity and potential confounders.

Jordan W, Dobrowolny H, Bahn S, Bernstein HG, Brigadski T, Frodl T, Isermann B, Lessmann V, Pilz J, Rodenbeck A, Schiltz K, Schwedhelm E, Tumani H, Wiltfang J, Guest PC, Steiner J.

Eur Arch Psychiatry Clin Neurosci. 2018 Mar;268(2):129-143. doi: 10.1007/s00406-016-0749-7. Epub 2016 Dec 2.

PMID:
27913877
31.

Evaluation of molecular brain changes associated with environmental stress in rodent models compared to human major depressive disorder: A proteomic systems approach.

Cox DA, Gottschalk MG, Stelzhammer V, Wesseling H, Cooper JD, Bahn S.

World J Biol Psychiatry. 2018;19(sup2):S63-S74. doi: 10.1080/15622975.2016.1252465. Epub 2016 Nov 25.

PMID:
27784204
32.

Blood-based immune-endocrine biomarkers of treatment response in depression.

Chan MK, Cooper JD, Bot M, Birkenhager TK, Bergink V, Drexhage HA, Steiner J, Rothermundt M, Penninx BW, Bahn S.

J Psychiatr Res. 2016 Dec;83:249-259. doi: 10.1016/j.jpsychires.2016.08.020. Epub 2016 Aug 31.

PMID:
27693950
33.

Cell Type-Specific Effects of Mutant DISC1: A Proteomics Study.

Xia M, Broek JA, Jouroukhin Y, Schoenfelder J, Abazyan S, Jaaro-Peled H, Sawa A, Bahn S, Pletnikov M.

Mol Neuropsychiatry. 2016 May;2(1):28-36. doi: 10.1159/000444587. Epub 2016 Apr 1.

34.

Altered apolipoprotein C expression in association with cognition impairments and hippocampus volume in schizophrenia and bipolar disorder.

Knöchel C, Kniep J, Cooper JD, Stäblein M, Wenzler S, Sarlon J, Prvulovic D, Linden DE, Bahn S, Stocki P, Ozcan S, Alves G, Carvalho AF, Reif A, Oertel-Knöchel V.

Eur Arch Psychiatry Clin Neurosci. 2017 Apr;267(3):199-212. doi: 10.1007/s00406-016-0724-3. Epub 2016 Aug 22.

PMID:
27549216
35.

Serum proteomic profiles of depressive subtypes.

Lamers F, Bot M, Jansen R, Chan MK, Cooper JD, Bahn S, Penninx BW.

Transl Psychiatry. 2016 Jul 12;6(7):e851. doi: 10.1038/tp.2016.115.

36.

Current concepts in chronic inflammatory diseases: Interactions between microbes, cellular metabolism, and inflammation.

Garn H, Bahn S, Baune BT, Binder EB, Bisgaard H, Chatila TA, Chavakis T, Culmsee C, Dannlowski U, Gay S, Gern J, Haahtela T, Kircher T, Müller-Ladner U, Neurath MF, Preissner KT, Reinhardt C, Rook G, Russell S, Schmeck B, Stappenbeck T, Steinhoff U, van Os J, Weiss S, Zemlin M, Renz H.

J Allergy Clin Immunol. 2016 Jul;138(1):47-56. doi: 10.1016/j.jaci.2016.02.046. Review.

PMID:
27373325
37.
38.

Proteomic systems evaluation of the molecular validity of preclinical psychosis models compared to schizophrenia brain pathology.

Cox DA, Gottschalk MG, Wesseling H, Ernst A, Cooper JD, Bahn S.

Schizophr Res. 2016 Nov;177(1-3):98-107. doi: 10.1016/j.schres.2016.06.012. Epub 2016 Jun 19.

PMID:
27335180
39.

Molecular serum signature of treatment resistant depression.

Ruland T, Chan MK, Stocki P, Grosse L, Rothermundt M, Cooper JD, Arolt V, Bahn S.

Psychopharmacology (Berl). 2016 Aug;233(15-16):3051-9. doi: 10.1007/s00213-016-4348-0. Epub 2016 Jun 20.

PMID:
27325393
40.

Cytokine production capacity in depression and anxiety.

Vogelzangs N, de Jonge P, Smit JH, Bahn S, Penninx BW.

Transl Psychiatry. 2016 May 31;6(5):e825. doi: 10.1038/tp.2016.92.

41.

Variation in serum biomarkers with sex and female hormonal status: implications for clinical tests.

Ramsey JM, Cooper JD, Penninx BW, Bahn S.

Sci Rep. 2016 May 31;6:26947. doi: 10.1038/srep26947.

42.

Sex Differences in Serum Markers of Major Depressive Disorder in the Netherlands Study of Depression and Anxiety (NESDA).

Ramsey JM, Cooper JD, Bot M, Guest PC, Lamers F, Weickert CS, Penninx BW, Bahn S.

PLoS One. 2016 May 27;11(5):e0156624. doi: 10.1371/journal.pone.0156624. eCollection 2016.

43.

System-based proteomic and metabonomic analysis of the Df(16)A+/- mouse identifies potential miR-185 targets and molecular pathway alterations.

Wesseling H, Xu B, Want EJ, Holmes E, Guest PC, Karayiorgou M, Gogos JA, Bahn S.

Mol Psychiatry. 2017 Mar;22(3):384-395. doi: 10.1038/mp.2016.27. Epub 2016 Mar 22.

44.

Synaptic vesicle dynamic changes in a model of fragile X.

Broek JAC, Lin Z, de Gruiter HM, van 't Spijker H, Haasdijk ED, Cox D, Ozcan S, van Cappellen GWA, Houtsmuller AB, Willemsen R, de Zeeuw CI, Bahn S.

Mol Autism. 2016 Mar 1;7:17. doi: 10.1186/s13229-016-0080-1. eCollection 2016.

45.

Development of a job rotation scheduling algorithm for minimizing accumulated work load per body parts.

Song J, Lee C, Lee W, Bahn S, Jung C, Yun MH.

Work. 2015;53(3):511-21. doi: 10.3233/WOR-152232.

PMID:
26835860
46.

Recombinant production of a shell matrix protein in Escherichia coli and its application to the biomimetic synthesis of spherulitic calcite crystals.

Song W, Bahn SY, Cha HJ, Pack SP, Choi YS.

Biotechnol Lett. 2016 May;38(5):809-16. doi: 10.1007/s10529-016-2039-x. Epub 2016 Jan 13.

PMID:
26758877
47.

Serum biomarkers predictive of depressive episodes in panic disorder.

Gottschalk MG, Cooper JD, Chan MK, Bot M, Penninx BW, Bahn S.

J Psychiatr Res. 2016 Feb;73:53-62. doi: 10.1016/j.jpsychires.2015.11.012. Epub 2015 Nov 24.

PMID:
26687614
48.

Determination of sex from various hand dimensions of Koreans.

Jee SC, Bahn S, Yun MH.

Forensic Sci Int. 2015 Dec;257:521.e1-521.e10. doi: 10.1016/j.forsciint.2015.10.014. Epub 2015 Oct 25.

PMID:
26597170
49.

Identification of an Immune-Neuroendocrine Biomarker Panel for Detection of Depression: A Joint Effects Statistical Approach.

Chan MK, Cooper JD, Bot M, Steiner J, Penninx BW, Bahn S.

Neuroendocrinology. 2016;103(6):693-710. doi: 10.1159/000442208. Epub 2015 Nov 19.

PMID:
26580065
50.

Commercialisation of Biomarker Tests for Mental Illnesses: Advances and Obstacles.

Chan MK, Cooper JD, Bahn S.

Trends Biotechnol. 2015 Dec;33(12):712-723. doi: 10.1016/j.tibtech.2015.09.010. Epub 2015 Nov 6. Review.

PMID:
26549771

Supplemental Content

Support Center